When you or your child next take a dose of antibiotics, consider that 90 percent of its raw ingredients were likely manufactured in China using biotechnologies. China has captured production of ...

Data and security laws are affecting scientists who stayed in China after COVID — but for some it’s still a great place to do ...

Insilico Medicine founder and CEO Alex Zhavoronkov told BioWorld that he tries to spend as much time as possible in China, because that's where the artificial intelligence (AI) drug development ...

Mumbai-based Aveo Pharmaceuticals, however, claimed the combination is approved by the relevant state drug authorities and is exported under necessary approval from the assistant drug controllers with ...

BridgeBio Pharma has received European approval for a drug that treats cardiomyopathy stemming from a rare metabolic condition, strengthening the biotech’s position to take market share from the ...

Feb 21 (Reuters) - The U.S. Food and Drug Administration approved Mirum Pharmaceuticals ... that interferes with the body's ability to process cholesterol. Patients with the disorder known ...

FibroGen sells its China unit to AstraZeneca for about $160M ... CD46 targeting antibody-drug conjugate, and FG-3180, our companion PET imaging agent, in mCRPC,” said Thane Wettig, Chief ...

BOSTON & SHENZHEN, China--(BUSINESS ... with the FDA throughout the drug development process, early regulatory guidance, and potential eligibility for accelerated approval, priority review ...

The FibroGen-AstraZeneca drug, marketed as Evrenzo, is currently approved in China, Europe, Japan, and over 40 other countries for the treatment of anemia in patients with chronic kidney disease.

An anemia drug developed under ... of roxadustat in China. Per terms of the China deal, profits are shared equally. In 2021, roxadustat won European approval but was rejected by the FDA, which ...